Dashboard
Manage Tickers

ORGS Orgenesis Inc.

OTC orgenesis.com


$ -0.85 (-85 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.00 $ 0.00 (0 %)
DIA $ 469.31 $ 0.00 (0 %)
SPY $ 672.16 $ 0.00 (0 %)
TLT $ 91.93 $ 0.00 (0 %)
GLD $ 373.66 $ 0.00 (0 %)
$ 0.15
-- x --
-- x --
-- - --
$ 0.00 - $ 5.89
29
na
775,387
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-20-2024 03-31-2024 10-Q
4 04-15-2024 12-31-2023 10-K
5 11-13-2023 09-30-2023 10-Q
6 08-10-2023 06-30-2023 10-Q
7 05-10-2023 03-31-2023 10-Q
8 03-22-2023 12-31-2022 10-K
9 11-10-2022 09-30-2022 10-Q
10 08-15-2022 06-30-2022 10-Q
11 05-23-2022 03-31-2022 10-Q
12 03-30-2022 12-31-2021 10-K
13 11-04-2021 09-30-2021 10-Q
14 08-05-2021 06-30-2021 10-Q
15 05-06-2021 03-31-2021 10-Q
16 03-09-2021 12-31-2020 10-K
17 11-05-2020 09-30-2020 10-Q
18 08-06-2020 06-30-2020 10-Q
19 05-08-2020 03-31-2020 10-Q
20 03-09-2020 12-31-2019 10-K
21 11-07-2019 09-30-2019 10-Q
22 08-08-2019 06-30-2019 10-Q
23 05-08-2019 03-31-2019 10-Q
24 02-13-2019 11-30-2018 10-K
25 10-12-2018 08-31-2018 10-Q
26 07-17-2018 05-31-2018 10-Q
27 04-16-2018 02-28-2018 10-Q
28 02-28-2018 12-31-2017 10-K
29 10-16-2017 08-31-2017 10-Q
30 07-24-2017 05-31-2017 10-Q
31 04-19-2017 02-28-2017 10-Q
32 02-28-2017 11-30-2016 10-K
33 10-14-2016 08-31-2016 10-Q
34 07-15-2016 05-31-2016 10-Q
35 04-14-2016 02-29-2016 10-Q
36 02-29-2016 11-30-2015 10-K
37 10-15-2015 08-31-2015 10-Q
38 07-15-2015 05-31-2015 10-Q
39 04-14-2015 02-28-2015 10-Q
40 02-19-2015 11-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

orgenesis-q3-eps-193-down-from-012-yoy-sales-34700k-up-from-11000k-yoy
Orgenesis Q3 EPS $(1.93) Down From $(0.12)...
11/13/2024 13:24:11

Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(1.93) per share. This is a 1508.33 percent decrease over losses of $(0.1...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
10/18/2024 16:30:58

dow-falls-over-100-points-netflix-posts-upbeat-results
Dow Falls Over 100 Points; Netflix Posts U...
10/18/2024 14:27:15

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
10/18/2024 12:09:16

Core News & Articles
Why Intuitive Surgical Shares Are Trading ...
10/18/2024 10:52:07

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
09/25/2024 12:55:05

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
09/24/2024 23:50:04

why-maison-solutions-shares-are-trading-higher-by-around-91-here-are-20-stocks-moving-premarket
Why Maison Solutions Shares Are Trading Hi...
09/24/2024 09:40:25

why-orgenesis-orgs-stock-is-down-23-today
Why Orgenesis (ORGS) Stock Is Down 23% Today
09/23/2024 18:08:23

Orgenesis shares are trading lower by 23% during Monday's session. The company announced a 1-for-10 reverse stock split.

orgenesis-approves-a-1-for-10-reverse-stock-split-effective-at-500-pm-eastern-time-on-september-24
Orgenesis Approves A 1-for-10 Reverse Stoc...
09/23/2024 11:07:24

orgenesis-announces-results-from-a-real-world-study-of-org-101-car-t-therapy-in-patients-with-cd19-acute-lymphoblastic-leukemia-top-line-efficacy-and-safety-data-from-the-study-had-a-complete-response-of-82-in-adult-patients-and-93-in-pediatric-patients
Orgenesis Announces Results From A Real-Wo...
08/29/2024 12:32:41

Orgenesis' CD19 CAR-T therapy, ORG-101, had a complete response (CR) of 82% in adults and 93% in pediatric patients with th...

orgenesis-announces-strategic-partnership-with-harley-street-healthcare-group-to-launch-a-longevity--wellness-initiative-globally-orgenesis-and-hshg-will-establish-a-jv-with-orgenesis-owning-49-and-hshg-owning-51-of-the-entity-hshg-has-agreed-to-invest-up-to-10m-over-3-years-into-orgenesis-and-the-joint-venture
Orgenesis Announces Strategic Partnership ...
08/14/2024 12:39:10

Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the ful...

why-rumble-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Rumble Shares Are Trading Higher By Ar...
08/13/2024 10:35:23

correction-orgenesis-q2-eps-loss-of-023-up-from-076-yoy-sales-24600k-up-from-11300k-yoy
CORRECTION: Orgenesis Q2 EPS Loss Of $(0.2...
08/09/2024 08:35:43

Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(0.23) per share. This is a 69.74 percent increase over losses of $(0.76)...

orgenesis-entered-purchase-deal-with-theracell-for-purchase-of-50-outstanding-ownership-rights--equity-interests-in-theracell-laboratories-ike-pursuant-to-deal-for-purchase-of-assets-co-to-pay-theracell-13m
Orgenesis Entered Purchase Deal With Thera...
07/12/2024 20:24:58

- SEC Filing

orgenesis-enters-asset-purchase-agreement-with-broaden-bioscience-for-car-t-processing-assets-will-pay-up-to-11m-based-on-third-party-valuation-payment-exceeding-1077m-debt-may-be-made-in-shares-or-a-note-with-24-month-amortization
Orgenesis Enters Asset Purchase Agreement ...
07/12/2024 19:03:10

why-kaival-brands-innovations-shares-are-trading-lower-by-47-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Kaival Brands Innovations Shares Are T...
06/21/2024 18:04:00

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 12:06:31

orgenesis-q1-eps-029-down-from-017-yoy-sales-14100k-miss-1200m-estimate
Orgenesis Q1 EPS $(0.29) Down From $0.17 Y...
05/21/2024 11:06:05

Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(0.29) per share. This is a 270.59 percent decrease over earnings of $0.1...

orgenesis-inc-files-for-mixed-shelf-of-up-to-100m--sec-filing
Orgenesis Inc Files For Mixed Shelf Of Up ...
04/22/2024 17:10:12

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION